Skip to main content

Toxicity and Antitumor Effect of 5-Fluorouracil and its Rescue by Uridine

  • Chapter
  • First Online:
Purine and Pyrimidine Metabolism in Man V

Abstract

The pyrimidine analog 5-fluorouracil (5FU) has been used in the treatment against several solid carcinomas, mainly of the colon, for several decades (1). However, overall response rate is only about 20%, while gastrointestinal and myeloid toxicity are dose-limiting (1). Research on 5FU has been directed towards enhancing 5FU anabolism by combination with e.g. methotrexate (2) or thymidine (3) and towards the development of several analogs of 5FU. One recent analog, Doxifluridine (5′-deoxy-5-fluorouridine, 5’dFUR) showed an improved therapeutic index against a broad range of murine and rat tumors (4,5) and therapeutic activity in human advanced rectosigmoid adenocarcinoma (6).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. B.A. Chabner, Pyrimidine antagonists, in: Pharmacologic principles of cancer treatment, B.A. Chabner, ed., pp. 183–212, Saunders, Philadelphia (1982).

    Google Scholar 

  2. E. Mim and J.R. Bertino, Chemotherapia II: 147–162 (1985).

    Google Scholar 

  3. C.W. Young, T.M. Woodcock and D.S. Martin, Cancer Treatm. Rep., 65, (suppl. 3): 83–87 (1981).

    CAS  Google Scholar 

  4. W. Bollag, H.R. Hartmann, Eur. J. Cancer, 16: 427–432 (1980).

    Article  CAS  Google Scholar 

  5. R.D. Armstrong and R.B. Diasio, Cancer Res. 40: 3333–3338 (1980).

    CAS  PubMed  Google Scholar 

  6. R. Abele, P. Alberto, S. Kaplan, P. Siegenthaler, V. Hoffman, H.J. Ryssel, D. Hartman, E.E. Holdener and F. Cavalli, J. Clin. Oncol. 1: 750–754 (1983).

    Article  CAS  Google Scholar 

  7. D.S. Martin, R.L. StolfiL, S.C. Sawyer, S. Spiegelman and C.W. Young, Cancer Res. 42: 3964–3970 (1982).

    CAS  PubMed  Google Scholar 

  8. P. Klubes, I. Cerna and M.A. Meldon, Cancer Chemother. Pharmacol. 8: 17–21 (1982).

    Article  CAS  Google Scholar 

  9. P. Klubes and I. Cerna, Cancer Res. 43: 3182–3186 (1983).

    CAS  PubMed  Google Scholar 

  10. T.H. Corbett, D.P. Griswold, B.J. Roberts, J.C. Peckham and F.M. Schabel, Cancer Res. 35: 2434–2439 (1975).

    CAS  PubMed  Google Scholar 

  11. E. Boven, W.J.F. van der Vijgh, M.M. Nauta, H.M.M. Schlüper and H.M. Pinedo, Cancer Res. 45: 86–90 (1985).

    CAS  PubMed  Google Scholar 

  12. P.J. van Kranenburg-Voogd, H.J. Keizer and L.M. van Putten, Eur. J. Cancer 14 (suppl.): 153–157 (1978).

    Article  Google Scholar 

  13. T.H. Corbett, D.P. Griswold, B.J. Roberts, J.C. Peckham and F.M. Schabel, Cancer 40: 2660–2690 (1977).

    Article  CAS  Google Scholar 

  14. E.A. de Bruyn, A.T. van Oosterom, U.R. Tjaden, H.J.E.M. van Reeuwijk and H.M. Pinedo, Cancer Res. in press (1985).

    Google Scholar 

  15. A.M. Yeager, J. Levin and F.C. Levin, Exp. Hematol. 11: 944–952 (1983).

    CAS  PubMed  Google Scholar 

  16. J.W. Darnofsky and R.E. Handschumacher, submitted (1985).

    Google Scholar 

  17. C.J. van Groeningen, A. Leyva, G.J. Peters, I. Kraal and H.M. Pinedo, Proc. AACR 35: 169 (abstract 670) (1984).

    Google Scholar 

  18. A. Leyva, C.J. van Groeningen, I. Kraal, H. Gall, G.J. Peters, J. Lankelma and H.M. Pinedo, Cancer Res. 44: 5928–5933 (1984).

    CAS  PubMed  Google Scholar 

  19. C.J. van Groeningen, A. Leyva, I. Kraal, G.J. Peters and H.M. Pinedo, submitted (1985).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Plenum Press, New York

About this chapter

Cite this chapter

Peters, G.J. et al. (1986). Toxicity and Antitumor Effect of 5-Fluorouracil and its Rescue by Uridine. In: Nyhan, W.L., Thompson, L.F., Watts, R.W.E. (eds) Purine and Pyrimidine Metabolism in Man V. Advances in Experimental Medicine and Biology, vol 195B. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-1248-2_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-1248-2_19

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4684-1250-5

  • Online ISBN: 978-1-4684-1248-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics